Core Viewpoint - The second batch of 11 floating fee rate new funds has been submitted for approval, expanding from the first batch of 26 funds, and includes both broad market selection products and industry-specific thematic products, particularly in sectors like pharmaceuticals, high-end equipment, and manufacturing [1][2]. Group 1: Fund Characteristics - The new floating fee rate funds are designed to meet investor demand for quality technology investment tools and leverage the research team's expertise in the technology growth sector [1][6]. - The second batch includes a diverse range of products, moving from broad market strategies to more specialized thematic strategies, indicating a richer variety of offerings to cater to different investor preferences [2][3]. - The management fee structure remains at three tiers: 1.2% (benchmark), 1.5% (upward adjustment), and 0.6% (downward adjustment), with specific conditions for fee application based on fund performance relative to benchmarks [2][3]. Group 2: Industry Focus - High-end equipment and pharmaceuticals are highlighted as key sectors for the new thematic funds, with high-end equipment being a core support of the modern industrial system and a significant part of technology investment [6]. - The pharmaceutical sector, particularly the innovative drug segment, is experiencing rapid revenue growth, with companies poised to enter international markets, indicating substantial future opportunities [6]. - The focus on biotechnology companies with global market potential and traditional pharmaceutical companies undergoing successful transformations is emphasized as a strategic investment direction [6].